Skip to content


Royal blue circle with white chart icon inside and royal blue swooshes on either side

Study Reporting

Clinicians, patients, and policymakers value PRO information but poor reporting (caused by non-adherence to reporting guidelines) undermines clinicians’ ability to use PRO data and limits its benefit to patients.

What’s In This Section: Study Reporting

The resources in this section guide the later phases of PRO research. Better reporting of PRO data will facilitate robust interpretation of clinical trial results to inform patient care and, ultimately, improve the quality of the global PRO evidence base.

For more information and resources on each of these steps, click below:


Back To Top